FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $807,162 | +69.8% | 380,737 | +281.3% | 0.00% | 0.0% |
| Q2 2023 | $475,248 | +45.3% | 99,842 | +584.6% | 0.00% | +100.0% |
| Q3 2022 | $327,000 | -9.7% | 14,583 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $362,000 | -36.0% | 14,604 | -0.0% | 0.00% | -50.0% |
| Q1 2022 | $566,000 | -33.8% | 14,610 | -0.0% | 0.00% | 0.0% |
| Q4 2021 | $855,000 | -88.4% | 14,615 | -88.3% | 0.00% | -91.7% |
| Q3 2021 | $7,380,000 | -79.6% | 124,508 | -70.2% | 0.02% | -80.5% |
| Q2 2021 | $36,223,000 | +1472.9% | 417,358 | +1548.1% | 0.12% | +1130.0% |
| Q4 2020 | $2,303,000 | -30.7% | 25,323 | -69.5% | 0.01% | -47.4% |
| Q3 2020 | $3,321,000 | +139.8% | 83,099 | +105.8% | 0.02% | +111.1% |
| Q2 2020 | $1,385,000 | – | 40,378 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |